Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

Clinical trial NCT05943041 · COMPLETED

Trial details

NCT number: NCT05943041
Sponsor: GILongevity
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Colorectal Cancer Sigmoid Colon Cancer Rectosigmoid Junction Cancer Cancer Rectal Cancer

Start date: 2023-04-28
Primary completion: 2023-12-22
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.